BA Venture Partners Invests $140 Million In 2005

BA Venture Partners (BAVP), which provides development capital for information technology and life sciences companies, invested $140 million in 28 companies during 2005. Of the nearly 30 deals, 10 were new BAVP investments. The remaining deals were follow on investments.

By None

BA Venture Partners (BAVP), which provides development capital for information technology and life sciences companies, invested $140 million in 28 companies during 2005.

Of the nearly 30 deals, 10 were new BAVP investments. The remaining deals were follow-on investments. During 2005, BAVP realized five liquidity events in its portfolio, including three acquisitions, one initial public offering, and one IPO filing.

“In 2005, we continued to see improvement in the overall economy and particularly in the sectors we have been watching and investing in during the last few years,” said Kate Mitchell, managing director with BAVP. “We invested in companies focused on Internet advertising, software-as-a-service, consumer electronics and healthcare.”

Mitchell said it was the first time, in recent years, that the company saw an increase in “M&A in the life sciences sector, and participated in this trend through the acquisition of Cellective Therapeutics by MedImmune.”

The company will continue to invest in internet services companies that can “build traction in the marketplace using less capital, consumer electronics component companies that will leverage the adoption of new technologies, and healthcare companies addressing large unmet medical needs,” said Lou Bock, managing director with BAVP.

«